The FDA has expanded the approval of Yuflyma (adalimumab-aaty) and its unbranded version to include the treatment of HS in patients aged 12 years and older and UV in pediatric patients aged 2 years ...
Pilocarpine 1.25% can boost distance corrected near visual acuity among other measures, in presbyopic adult eyes with dark irides.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback